Sign in

CIK 0001566044

  • Non-accelerated filer
  • Smaller reporting company

Yarrow Bioscience, Inc.

Sign in to watch
Ticker
YARW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
453757789
Phone
+1 203-433-7577
Business address
470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
Former names
VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 2 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-20 LEPORE PATRICK G Director Purchase +20,000 $2.48 $50K 23,472
2023-03-20 Harsch Mutya Chief Legal Officer and GC Purchase +10,000 $2.50 $25K 22,721
2022-12-31 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,813 $0.15 $272 229,144
2022-12-31 Stuart Iain Chief Scientific Officer Shares withheld for taxes −1,720 $0.15 $258 220,252
2022-12-31 Zeronda Tyler Chief Financial Officer Shares withheld for taxes −354 $0.15 $53 173,005
2022-12-31 Domzalski David President and CEO Shares withheld for taxes −10,685 $0.15 $2K 1,064,290
2022-11-30 Domzalski David President and CEO Grant or award +34,705 $0.20 $7K 1,074,975
2022-09-30 Zeronda Tyler CFO Shares withheld for taxes −353 $0.22 $79 173,359
2022-09-30 Stuart Iain Chief Scientific Officer Shares withheld for taxes −1,719 $0.22 $383 221,972
2022-09-30 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,813 $0.22 $404 230,957
2022-09-30 Domzalski David President and CEO Shares withheld for taxes −10,683 $0.22 $2K 1,040,270
2022-08-10 Sandoval Elisabeth Director Grant or award · Stock Options +20,500 20,500
2022-08-10 LEPORE PATRICK G Director Grant or award · Stock Options +20,500 20,500
2022-08-10 Bruno Anthony D Director Grant or award · Stock Options +20,500 20,500
2022-08-10 Basta Steven L Director Grant or award · Stock Options +20,500 20,500
2022-08-10 BARBARI SHARON Director Grant or award · Stock Options +20,500 20,500
2022-06-30 Zeronda Tyler CFO Shares withheld for taxes −354 $0.39 $138 173,712
2022-06-30 Stuart Iain Chief Scientific Officer Shares withheld for taxes −1,719 $0.39 $669 223,691
2022-06-30 Harsch Mutya Chief Legal Officer and GC Shares withheld for taxes −1,813 $0.39 $705 232,770
2022-06-30 Domzalski David President and CEO Shares withheld for taxes −10,683 $0.39 $4K 1,050,953

Page 7 of 22 · 425 trades